335 related articles for article (PubMed ID: 19189661)
1. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study.
Ghous Z; Akhter J; Pourgholami MH; Morris DL
Anticancer Res; 2008; 28(6A):3757-61. PubMed ID: 19189661
[TBL] [Abstract][Full Text] [Related]
2. Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089.
Zhang X; Jiang F; Li P; Li C; Ma Q; Nicosia SV; Bai W
Clin Cancer Res; 2005 Jan; 11(1):323-8. PubMed ID: 15671562
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D analogs: new therapeutic agents for the treatment of squamous cancer and its associated hypercalcemia.
Yu J; Papavasiliou V; Rhim J; Goltzman D; Kremer R
Anticancer Drugs; 1995 Feb; 6(1):101-8. PubMed ID: 7756673
[TBL] [Abstract][Full Text] [Related]
5. Reversal of hypercalcemia with the vitamin D analogue EB1089 in a human model of squamous cancer.
El Abdaimi K; Papavasiliou V; Rabbani SA; Rhim JS; Goltzman D; Kremer R
Cancer Res; 1999 Jul; 59(14):3325-8. PubMed ID: 10416587
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo].
Wang C; Tang C; Tang L
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709
[TBL] [Abstract][Full Text] [Related]
7. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
Haq M; Kremer R; Goltzman D; Rabbani SA
J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
[TBL] [Abstract][Full Text] [Related]
8. [Effects of vitamin D analogue EB1089 on proliferation and apoptosis of hepatic carcinoma cells].
Luo WJ; Chen JY; Xu W; Zhao F; Chen YM; Shen XF
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Nov; 38(6):415-8. PubMed ID: 15569516
[TBL] [Abstract][Full Text] [Related]
9. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA
Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo.
Hitomi M; Yokoyama F; Kita Y; Nonomura T; Masaki T; Yoshiji H; Inoue H; Kinekawa F; Kurokohchi K; Uchida N; Watanabe S; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):713-20. PubMed ID: 15703828
[TBL] [Abstract][Full Text] [Related]
11. EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro.
James SY; Mercer E; Brady M; Binderup L; Colston KW
Br J Pharmacol; 1998 Nov; 125(5):953-62. PubMed ID: 9846632
[TBL] [Abstract][Full Text] [Related]
12. [Study on the inhibitory effect of small tripeptide CMS024 on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis].
Li Y; Tang ZY; Wang L; Yao Z; Lu R; Xue Q; Gao DM; Chen J
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(8):675-9. PubMed ID: 15130313
[TBL] [Abstract][Full Text] [Related]
13. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
14. [Regulatory mechanism of EB1089 for hepatocarcinoma cell proliferation].
Luo W; Chen J; Zhang X; Wang W
Wei Sheng Yan Jiu; 2004 Mar; 33(2):140-3. PubMed ID: 15208989
[TBL] [Abstract][Full Text] [Related]
15. EB1089 induces Skp2-dependent p27 accumulation, leading to cell growth inhibition and cell cycle G1 phase arrest in human hepatoma cells.
Luo W; Chen Y; Liu M; Du K; Zheng G; Cai T; Zhang W; Zhao F; Yao T; Yang R; Chen J
Cancer Invest; 2009 Jan; 27(1):29-37. PubMed ID: 19160095
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo inhibition of liver cancer cells by 1,25-dihydroxyvitamin D3.
Pourgholami MH; Akhter J; Lu Y; Morris DL
Cancer Lett; 2000 Apr; 151(1):97-102. PubMed ID: 10766428
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo.
Schwartz GG; Hill CC; Oeler TA; Becich MJ; Bahnson RR
Urology; 1995 Sep; 46(3):365-9. PubMed ID: 7660511
[TBL] [Abstract][Full Text] [Related]
18. Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinoma.
Wada A; Fukui K; Sawai Y; Imanaka K; Kiso S; Tamura S; Shimomura I; Hayashi N
J Hepatol; 2006 Jan; 44(1):142-50. PubMed ID: 16298452
[TBL] [Abstract][Full Text] [Related]
19. Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone.
Nagler A; Ohana M; Shibolet O; Shapira MY; Alper R; Vlodavsky I; Pines M; Ilan Y
Eur J Cancer; 2004 Jun; 40(9):1397-403. PubMed ID: 15177499
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the inhibitory effect of tripeptide tyroservatide on growth of human hepatocellular carcinoma using a hollow fiber assay].
Shi LX; Lu R; Wang L; Zhou CL; Xu Q; Zhu ZF; Ma R; Zhang HL; Jia J; Fu Z; Yao Z
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):725-8. PubMed ID: 19173797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]